Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Vasogen files for protection of patient-specific treatment of GvHD

Oct. 27, 1998

Simulect gets the go-ahead from the European Commission

Oct. 23, 1998

Astra patents novel immunosuppressive agents

Oct. 22, 1998

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Oct. 21, 1998

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Data safety monitoring board deems Nabi S. aureus vaccine safe in hemodialysis patients

Oct. 16, 1998

Aquila reports preliminary results of phase II trial of pneumococcal vaccine

Oct. 16, 1998

New compound reported in clinical development at Lilly

Oct. 15, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...